|
|
||||||||
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg, Martinistrasse 52, 2000 Hamburg 20, Federal Republic of Germany
A search was made in LCM virus-immune mice for virus-specific antibodies. With the help of an L-cell plaque assay, neutralizing antibody was readily detected. There were no essential differences between mouse strains, but marked differences existed between virus strains. Whereas the inoculation of either large or small doses of WE strain virus led to the early production of considerable concentrations of neutralizing antibody, in the case of E-350 strain virus, high doses were required and a much longer time interval had to elapse before the threshold of detection was attained. In addition to neutralizing antibody, LCM virus-infected mice produced sensitizing antibody (detected by the enhancing effect of an anti-mouse Ig anti-serum on the ability of a serum to reduce virus infectivity) and complement-fixing antibody. Previous failures to detect neutralizing antibody in LCM virus-immune mice might have been caused by properties of the chosen virus, but in many instances lack of a suitable assay host is a more likely explanation.
Received 29 March 1979;
accepted 20 July 1979.
This article has been cited by other articles:
![]() |
K. J. Maloy, I. Erdmann, V. Basch, S. Sierro, T. A. Kramps, R. M. Zinkernagel, S. Oehen, and T. M. Kündig Intralymphatic immunization enhances DNA vaccination PNAS, February 22, 2001; (2001) 51630798. [Abstract] [Full Text] |
||||
![]() |
K. J. Maloy, C. Burkhart, T. M. Junt, B. Odermatt, A. Oxenius, L. Piali, R. M. Zinkernagel, and H. Hengartner CD4+ T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability J. Exp. Med., June 19, 2000; 191(12): 2159 - 2170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lopez-Macias, U. Kalinke, M. Cascalho, M. Wabl, H. Hengartner, R. M. Zinkernagel, and A. Lamarre Secondary Rearrangements and Hypermutation Generate Sufficient B Cell Diversity to Mount Protective Antiviral Immunoglobulin Responses J. Exp. Med., June 7, 1999; 189(11): 1791 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Seiler, U. Kalinke, T. Rulicke, E. M. Bucher, C. Bose, R. M. Zinkernagel, and H. Hengartner Enhanced Virus Clearance by Early Inducible Lymphocytic Choriomeningitis Virus-Neutralizing Antibodies in Immunoglobulin-Transgenic Mice J. Virol., March 1, 1998; 72(3): 2253 - 2258. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sedlik, M.-F. Saron, J. Sarraseca, I. Casal, and C. Leclerc Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells PNAS, July 8, 1997; 94(14): 7503 - 7508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Saron, C. Fayolle, P. Sebo, D. Ladant, A. Ullmann, and C. Leclerc Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus PNAS, April 1, 1997; 94(7): 3314 - 3319. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Maloy, I. Erdmann, V. Basch, S. Sierro, T. A. Kramps, R. M. Zinkernagel, S. Oehen, and T. M. Kundig Intralymphatic immunization enhances DNA vaccination PNAS, March 13, 2001; 98(6): 3299 - 3303. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |